Page last updated: 2024-10-30

leflunomide and Cogan Syndrome

leflunomide has been researched along with Cogan Syndrome in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Cogan Syndrome: A condition consisting of inflammatory eye disease usually presenting as interstitial KERATITIS, vestibuloauditory dysfunction, and large- to medium-vessel vasculitis.

Research Excerpts

ExcerptRelevanceReference
"We present a case of Cogan's syndrome remission associated with leflunomide (LEF) in a juvenile patient."1.35Leflunomide for the successful management of juvenile Cogan's syndrome. ( Bao, X; Cai, Y; Cao, L; Xie, L, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xie, L1
Cai, Y1
Bao, X1
Cao, L1

Other Studies

1 other study available for leflunomide and Cogan Syndrome

ArticleYear
Leflunomide for the successful management of juvenile Cogan's syndrome.
    Clinical rheumatology, 2009, Volume: 28, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Child; Cogan Syndrome; Drug Therapy, C

2009